Multiple Therapies,
One Virus.
KALIVIR is developing cutting-edge, next-generation
oncolytic viral immunotherapy programs for treatment
of cancer. We design safe and potent oncolytic
product candidates to treat patients across mulltiple
tumor types. Learn more about us
NEWS AND EVENTS READ MORE January 25 –27, 2022 – Taming the Double-Edged Sword of TGF-β to Accelerate Clinical Success in Immuno-Oncology
here.